Newborn Screening for Pompe Disease: Pennsylvania Experience

Newborn Screening for Pompe Disease: Pennsylvania Experience

Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS/MS) and full sequencing of the GAA gene is perfor...

Full description

Bibliographic Details
Main Authors: Can Ficicioglu, Rebecca C. Ahrens-Nicklas, Joshua Barch, Sanmati R. Cuddapah, Brenda S. DiBoscio, James C. DiPerna, Patricia L. Gordon, Nadene Henderson, Caitlin Menello, Nicole Luongo, Damara Ortiz, Rui Xiao
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Neonatal Screening
Subjects:
Pompe disease
newborn screening
alpha glucosidase
Online Access:https://www.mdpi.com/2409-515X/6/4/89

Internet

https://www.mdpi.com/2409-515X/6/4/89

Similar Items